Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Dec;21(6):224.
doi: 10.1136/ebmed-2016-110562. Epub 2016 Oct 18.

Existing Evidence Is Insufficient to Justify Metformin or Other Agents as First-Line Therapy for Type 2 Diabetes

Affiliations
Comment

Existing Evidence Is Insufficient to Justify Metformin or Other Agents as First-Line Therapy for Type 2 Diabetes

Rene Rodriguez-Gutierrez et al. Evid Based Med. .

Comment on

Similar articles

See all similar articles
Feedback